Literature DB >> 20644093

Host factors and cancer progression: biobehavioral signaling pathways and interventions.

Susan K Lutgendorf1, Anil K Sood, Michael H Antoni.   

Abstract

Whereas evidence for the role of psychosocial factors in cancer initiation has been equivocal, support continues to grow for links between psychological factors such as stress, depression, and social isolation and progression of cancer. In vitro, in vivo, and clinical studies show that stress- related processes can impact pathways implicated in cancer progression, including immuno-regulation, angiogenesis, and invasion. Contributions of systemic factors, such as stress hormones to the crosstalk between tumor and stromal cells, appear to be critical in modulating downstream signaling pathways with important implications for disease progression. Inflammatory pathways may also be implicated in fatigue and other factors related to quality of life. Although substantial evidence supports a positive effect of psychosocial interventions on quality of life in cancer, the clinical evidence for efficacy of stress-modulating psychosocial interventions in slowing cancer progression remains inconclusive, and the biobehavioral mechanisms that might explain such effects are still being established. This article reviews research findings to date and outlines future avenues of research in this area.

Entities:  

Mesh:

Year:  2010        PMID: 20644093      PMCID: PMC2940426          DOI: 10.1200/JCO.2009.26.9357

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  96 in total

1.  Stressful life events and risk of breast cancer in 10,808 women: a cohort study.

Authors:  Kirsi Lillberg; Pia K Verkasalo; Jaakko Kaprio; Lyly Teppo; Hans Helenius; Markku Koskenvuo
Journal:  Am J Epidemiol       Date:  2003-03-01       Impact factor: 4.897

2.  Love, marriage, and divorce: newlyweds' stress hormones foreshadow relationship changes.

Authors:  Janice K Kiecolt-Glaser; Cynthia Bane; Ronald Glaser; William B Malarkey
Journal:  J Consult Clin Psychol       Date:  2003-02

3.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

4.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

5.  Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells.

Authors:  T L Drell; J Joseph; K Lang; B Niggemann; K S Zaenker; F Entschladen
Journal:  Breast Cancer Res Treat       Date:  2003-07       Impact factor: 4.872

Review 6.  Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?

Authors:  Sandra Sephton; David Spiegel
Journal:  Brain Behav Immun       Date:  2003-10       Impact factor: 7.217

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus.

Authors:  Deidre Byrnes Pereira; Michael H Antoni; Aimee Danielson; Trudi Simon; JoNell Efantis-Potter; Charles S Carver; Ron E F Durán; Gail Ironson; Nancy Klimas; Mary Jo O'Sullivan
Journal:  Psychosom Med       Date:  2003 May-Jun       Impact factor: 4.312

9.  The association between stressful life events and breast cancer risk: a meta-analysis.

Authors:  Saskia F A Duijts; Maurice P A Zeegers; Bart Vd Borne
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

Review 10.  Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?

Authors:  Guy Shakhar; Shamgar Ben-Eliyahu
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

View more
  81 in total

1.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  Perspectives on personalized cancer care.

Authors:  Garrett M Dancika; Dan Theodorescu
Journal:  Urol Oncol       Date:  2012 Mar-Apr       Impact factor: 3.498

Review 3.  Psychosocial care in cancer.

Authors:  Samantha B Artherholt; Jesse R Fann
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

4.  Editorial for International Journal of Behavioral Medicine: special issue on cancer.

Authors:  Michael H Antoni
Journal:  Int J Behav Med       Date:  2011-12

5.  Beta-adrenergic blocking drugs in breast cancer: a perspective review.

Authors:  Thomas I Barron; Linda Sharp; Kala Visvanathan
Journal:  Ther Adv Med Oncol       Date:  2012-05       Impact factor: 8.168

Review 6.  The embodiment of adverse childhood experiences and cancer development: potential biological mechanisms and pathways across the life course.

Authors:  Michelle Kelly-Irving; Laurence Mabile; Pascale Grosclaude; Thierry Lang; Cyrille Delpierre
Journal:  Int J Public Health       Date:  2012-05-16       Impact factor: 3.380

7.  Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up.

Authors:  Michael H Antoni; Jamie M Jacobs; Laura C Bouchard; Suzanne C Lechner; Devika R Jutagir; Lisa M Gudenkauf; Bonnie B Blomberg; Stefan Glück; Charles S Carver
Journal:  Gen Hosp Psychiatry       Date:  2016-10-22       Impact factor: 3.238

Review 8.  Biological Basis for the Clustering of Symptoms.

Authors:  Debra Lynch Kelly; Kristin Dickinson; Chao-Pin Hsiao; Nada Lukkahatai; Velda Gonzalez-Marrero; Margaret McCabe; Leorey N Saligan
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

9.  Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Authors:  Devika R Jutagir; Bonnie B Blomberg; Charles S Carver; Suzanne C Lechner; Kiara R Timpano; Laura C Bouchard; Lisa M Gudenkauf; Jamie M Jacobs; Alain Diaz; Susan K Lutgendorf; Steve W Cole; Aaron S Heller; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

10.  Impact of cardiovascular comorbidity on ovarian cancer mortality.

Authors:  Eileen H Shinn; Daniel J Lenihan; Diana L Urbauer; Karen M Basen-Engquist; Alan Valentine; Laura Palmero; Myrshia L Woods; Pooja Patel; Alpa M Nick; Mian M K Shahzad; Rebecca L Stone; Antoinette Golden; Emma Atkinson; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.